Lingyun J. Shao

Shanghai Key Laboratory Of Infectious Diseases And Biosafety Emergency Response
Shanghai, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 86 publications

Immune checkpoint inhibitors in infectious diseases: therapeutic reinvigoration, immunopathology, and precision targeting.

Immune checkpoint inhibitors in infectious diseases: therapeutic reinvigoration, immunopathology, and precision targeting.

Journal: Frontiers in immunology

Published: May 29, 2026

BFLF1 gene polymorphisms are associated with increased mortality in patients with EBV-associated diseases.

BFLF1 gene polymorphisms are associated with increased mortality in patients with EBV-associated diseases.

Journal: Hereditas

Published: May 05, 2026

A multi-glycoprotein synergized recombinant virus system resolved the research dilemma of Epstein-Barr virus entry and facilitated the development of entry-specific drugs or vaccines.

A multi-glycoprotein synergized recombinant virus system resolved the research dilemma of Epstein-Barr virus entry and facilitated the development of entry-specific drugs or vaccines.

Journal: Current research in microbial sciences

Published: March 09, 2026

Efficacy of sequential lateral position management in patients with chronic wounds and pulmonary complications: a prospective RCT

Efficacy of sequential lateral position management in patients with chronic wounds and pulmonary complications: a prospective RCT

Journal: Zhonghua shao shang yu chuang mian xiu fu za zhi

Published: January 29, 2026

Mendelian susceptibility to mycobacterial disease: IFN-γ-driven immunity collapse underlies heterogeneous infections.

Mendelian susceptibility to mycobacterial disease: IFN-γ-driven immunity collapse underlies heterogeneous infections.

Journal: Frontiers in immunology

Published: January 05, 2026

A Novel Therapy With a One-Month Ultrashort Regimen to Halt Progression From Latent Infection to Active Tuberculosis Among Close Contacts (The TB‑YOUTH Study): Protocol for a Cluster Randomized Controlled Trial.

A Novel Therapy With a One-Month Ultrashort Regimen to Halt Progression From Latent Infection to Active Tuberculosis Among Close Contacts (The TB‑YOUTH Study): Protocol for a Cluster Randomized Controlled Trial.

Journal: JMIR research protocols

Published: December 15, 2025

A bidimensional early intervention strategy of standard of care in combination with corticosteroids in elderly patients with mild to moderate COVID-19 (BEAT-COV study): a multicentre, open-label, randomized controlled trial.

A bidimensional early intervention strategy of standard of care in combination with corticosteroids in elderly patients with mild to moderate COVID-19 (BEAT-COV study): a multicentre, open-label, randomized controlled trial.

Journal: BMC infectious diseases

Published: December 01, 2025

IL-17A-producing γδ T cells control pulmonary Mycobacterium abscessus infection in mice.

IL-17A-producing γδ T cells control pulmonary Mycobacterium abscessus infection in mice.

Journal: Nature microbiology

Published: July 04, 2025

Retrospective Review of Children Hospitalized for Epstein-Barr Virus-Related Infectious Mononucleosis.

Retrospective Review of Children Hospitalized for Epstein-Barr Virus-Related Infectious Mononucleosis.

Journal: Pathogens (Basel, Switzerland)

Published: June 14, 2025

The splenic norepinephrine-β2-adrenergic receptor axis aggravates sepsis-associated acute kidney injury via neutrophil-mediated immunosuppression.

The splenic norepinephrine-β2-adrenergic receptor axis aggravates sepsis-associated acute kidney injury via neutrophil-mediated immunosuppression.

Journal: Kidney international

Published: May 12, 2025

QuantiFERON-TB supernatant-based biomarkers predicting active tuberculosis progression.

QuantiFERON-TB supernatant-based biomarkers predicting active tuberculosis progression.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: January 26, 2025

Prevalence, Progression, and Treatment of Asymptomatic Tuberculosis: A Prospective Cohort Study in Lanxi County, Zhejiang Province, China.

Prevalence, Progression, and Treatment of Asymptomatic Tuberculosis: A Prospective Cohort Study in Lanxi County, Zhejiang Province, China.

Journal: Open forum infectious diseases

Published: January 23, 2025

Showing 1-12 of 86

Last Updated: 09/26/2026